Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy.

Kuusisto J, Kärjä V, Sipola P, Kholová I, Peuhkurinen K, Jääskeläinen P, Naukkarinen A, Ylä-Herttuala S, Punnonen K, Laakso M.

Heart. 2012 Jul;98(13):1007-13. doi: 10.1136/heartjnl-2011-300960. Epub 2012 Mar 24.

PMID:
22447464
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY.

Circ Cardiovasc Imaging. 2013 May 1;6(3):415-22. doi: 10.1161/CIRCIMAGING.112.000333. Epub 2013 Apr 2.

PMID:
23549607
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.

Moravsky G, Ofek E, Rakowski H, Butany J, Williams L, Ralph-Edwards A, Wintersperger BJ, Crean A.

JACC Cardiovasc Imaging. 2013 May;6(5):587-96. doi: 10.1016/j.jcmg.2012.09.018. Epub 2013 Apr 10.

PMID:
23582356
[PubMed - indexed for MEDLINE]
Free Article
4.

Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.

Song BG, Yang HS, Hwang HK, Kang GH, Park YH, Chun WJ, Oh JH.

Clin Cardiol. 2013 Jan;36(1):31-5. doi: 10.1002/clc.22062. Epub 2012 Oct 15. Retraction in: Clin Cardiol. 2013 Nov;36(11):711.

PMID:
23070984
[PubMed - indexed for MEDLINE]
5.

Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.

Sipola P, Magga J, Husso M, Jääskeläinen P, Peuhkurinen K, Kuusisto J.

Eur Radiol. 2011 Jul;21(7):1383-9. doi: 10.1007/s00330-011-2065-y. Epub 2011 Jan 28.

PMID:
21274714
[PubMed - indexed for MEDLINE]
6.

Coronary telangiectasia associated with hypertrophic cardiomyopathy.

Frustaci A, Lanfranchi G, Bellin M, Chimenti C.

Eur J Heart Fail. 2012 Dec;14(12):1332-7. doi: 10.1093/eurjhf/hfs125. Epub 2012 Aug 5.

PMID:
22869457
[PubMed - indexed for MEDLINE]
7.

The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.

Maron MS.

J Cardiovasc Transl Res. 2009 Dec;2(4):415-25. doi: 10.1007/s12265-009-9136-3. Epub 2009 Nov 7. Review.

PMID:
20560000
[PubMed - indexed for MEDLINE]
8.

Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.

Sipola P, Lauerma K, Jääskeläinen P, Laakso M, Peuhkurinen K, Manninen H, Aronen HJ, Kuusisto J.

Radiology. 2005 Sep;236(3):815-24. Epub 2005 Jul 12.

PMID:
16014439
[PubMed - indexed for MEDLINE]
9.

Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.

Khan R, Massel D, Stirrat J, Scholl D, Wisenberg G, Thompson T, Drangova M, White JA.

Int J Cardiovasc Imaging. 2013 Feb;29(2):395-404. doi: 10.1007/s10554-012-0107-4. Epub 2012 Aug 9.

PMID:
22875171
[PubMed - indexed for MEDLINE]
10.

Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy.

Kai H, Muraishi A, Sugiu Y, Nishi H, Seki Y, Kuwahara F, Kimura A, Kato H, Imaizumi T.

Circ Res. 1998 Sep 21;83(6):594-601.

PMID:
9742054
[PubMed - indexed for MEDLINE]
Free Article
11.

Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.

Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F.

J Am Coll Cardiol. 2011 Aug 16;58(8):839-48. doi: 10.1016/j.jacc.2011.05.018.

PMID:
21835320
[PubMed - indexed for MEDLINE]
Free Article
12.

Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.

Almaas VM, Haugaa KH, Strøm EH, Scott H, Smith HJ, Dahl CP, Geiran OR, Endresen K, Aakhus S, Amlie JP, Edvardsen T.

Heart. 2014 Apr;100(8):631-8. doi: 10.1136/heartjnl-2013-304923. Epub 2013 Dec 24.

PMID:
24368281
[PubMed - indexed for MEDLINE]
13.

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.

Fluechter S, Kuschyk J, Wolpert C, Doesch C, Veltmann C, Haghi D, Schoenberg SO, Sueselbeck T, Germans T, Streitner F, Borggrefe M, Papavassiliu T.

J Cardiovasc Magn Reson. 2010 May 21;12:30. doi: 10.1186/1532-429X-12-30.

PMID:
20492668
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

Ho CY, López B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, González A, Colan SD, Seidman JG, Díez J, Seidman CE.

N Engl J Med. 2010 Aug 5;363(6):552-63. doi: 10.1056/NEJMoa1002659.

PMID:
20818890
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps.

Aletras AH, Tilak GS, Hsu LY, Arai AE.

Circ Cardiovasc Imaging. 2011 Jul;4(4):425-34. doi: 10.1161/CIRCIMAGING.110.958751. Epub 2011 May 16.

PMID:
21576279
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.

Prinz C, Schwarz M, Ilic I, Laser KT, Lehmann R, Prinz EM, Bitter T, Vogt J, van Buuren F, Bogunovic N, Horstkotte D, Faber L.

Can J Cardiol. 2013 Mar;29(3):358-63. doi: 10.1016/j.cjca.2012.05.004. Epub 2012 Jun 30.

PMID:
22749647
[PubMed - indexed for MEDLINE]
17.

Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.

Blauwet LA, Ackerman MJ, Edwards WD, Riehle DL, Ommen SR.

Cardiovasc Pathol. 2009 Sep-Oct;18(5):262-8. doi: 10.1016/j.carpath.2008.08.003. Epub 2008 Oct 2.

PMID:
18835191
[PubMed - indexed for MEDLINE]
18.

Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Elmas E, Doesch C, Fluechter S, Freundt M, Weiss C, Lang S, Kälsch T, Haghi D, Papassotiriou J, Kunde J, Schoenberg SO, Borggrefe M, Papavassiliu T.

Int J Cardiovasc Imaging. 2011 Apr;27(4):547-56. doi: 10.1007/s10554-010-9704-2. Epub 2010 Sep 26.

PMID:
20872251
[PubMed - indexed for MEDLINE]
19.

Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.

Conte MR, Bongioanni S, Chiribiri A, Leuzzi S, Lardone E, Di Donna P, Pizzuti A, Luceri S, Cesarani F, Mabritto B, Zoccai GB, Bonamini R, Gaita F.

Am Heart J. 2011 Jun;161(6):1073-7. doi: 10.1016/j.ahj.2011.03.022.

PMID:
21641353
[PubMed - indexed for MEDLINE]
20.

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.

Circ Heart Fail. 2010 Jan;3(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.109.854026. Epub 2009 Oct 22.

PMID:
19850699
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk